Search Results - "Strong, John M."

Refine Results
  1. 1
  2. 2

    Quantitative Evaluation of Pharmacokinetic Inhibition of CYP3A Substrates by Ketoconazole: A Simulation Study by Zhao, Ping, Ragueneau-Majlessi, Isabelle, Zhang, Lei, Strong, John M., Reynolds, Kellie S., Levy, Rene H., Thummel, Kenneth E., Huang, Shiew-Mei

    Published in Journal of clinical pharmacology (01-03-2009)
    “…The US Food and Drug Administration draft drug interaction guidance recommends that 400 mg ketoconazole (KTZ) be administered once daily for several days…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Scientific Perspectives on Drug Transporters and Their Role in Drug Interactions by Zhang, Lei, Strong, John M, Qiu, Wei, Lesko, Lawrence J, Huang, Shiew-Mei

    Published in Molecular pharmaceutics (01-01-2006)
    “…Recently, increased interest in drug transporters and research in this area has revealed that drug transporters play an important role in modulating drug…”
    Get full text
    Journal Article
  5. 5

    Reaction of Geldanamycin and C17-Substituted Analogues with Glutathione:  Product Identifications and Pharmacological Implications by Cysyk, Richard L, Parker, Robert J, Barchi, Joseph J, Steeg, Patricia S, Hartman, Neil R, Strong, John M

    Published in Chemical research in toxicology (01-03-2006)
    “…17-Dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and 17-allylamino-17-demethoxygeldanamycin (17-AAG) are two derivatives of geldanamycin (GA) that…”
    Get full text
    Journal Article
  6. 6

    Phase I study of the synthetic triterpenoid, 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid (CDDO), in advanced solid tumors by Speranza, Giovanna, Gutierrez, Martin E., Kummar, Shivaani, Strong, John M., Parker, Robert J., Collins, Jerry, Yu, Yunkai, Cao, Liang, Murgo, Anthony J., Doroshow, James H., Chen, Alice

    Published in Cancer chemotherapy and pharmacology (01-02-2012)
    “…Background The triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic Acid (CDDO, previously RTA 401) is a multifunctional molecule that controls cellular growth…”
    Get full text
    Journal Article
  7. 7

    Stability and Comparative Metabolism of Selected Felbamate Metabolites and Postulated Fluorofelbamate Metabolites by Postmitochondrial Suspensions by Parker, Robert J, Hartman, Neil R, Roecklein, Bryan A, Mortko, Henry, Kupferberg, Harvey J, Stables, James, Strong, John M

    Published in Chemical research in toxicology (01-12-2005)
    “…Evidence has been presented suggesting that a reactive metabolite, 2-phenylpropenal (ATPAL), may be responsible for the toxicities observed during therapy with…”
    Get full text
    Journal Article
  8. 8

    Reactivity of atropaldehyde, a felbamate metabolite in human liver tissue in vitro by Kapetanovic, Izet M, Torchin, Cynthia D, Strong, John M, Yonekawa, Wayne D, Lu, Chuang, Li, Albert P, Dieckhaus, Christine M, Santos, Webster L, Macdonald, Timothy L, Sofia, R.Duane, Kupferberg, Harvey J

    Published in Chemico-biological interactions (10-11-2002)
    “…Antiepileptic therapy with a broad spectrum drug felbamate (FBM) has been limited due to reports of hepatotoxicity and aplastic anemia associated with its use…”
    Get full text
    Journal Article
  9. 9

    Potentially Reactive Cyclic Carbamate Metabolite of the Antiepileptic Drug Felbamate Produced by Human Liver Tissue In Vitro by KAPETANOVIC, I. M, TORCHIN, C. D, THOMPSON, C. D, MILLER, T. A, MCNEILLY, P. J, MACDONALD, T. L, KUPFERBERG, H. J, PERHACH, J. L, SOFIA, R. D, STRONG, J. M

    Published in Drug metabolism and disposition (01-11-1998)
    “…Felbamate (FBM) is a novel antiepileptic drug that was approved in 1993 for treatment of several forms of epilepsy. After its introduction, toxic reactions…”
    Get full text
    Journal Article
  10. 10

    Production of intracellular 35S-glutathione by rat and human hepatocytes for the quantification of xenobiotic reactive intermediates by Hartman, Neil R, Cysyk, Richard L, Bruneau-Wack, Claudine, Thénot, Jean-Paul, Parker, Robert J, Strong, John M

    Published in Chemico-biological interactions (10-11-2002)
    “…The quantification and identification of xenobiotic reactive intermediates is difficult in the absence of highly radiolabeled drug. We have developed a method…”
    Get full text
    Journal Article
  11. 11
  12. 12

    4-demethylpenclomedine, an antitumor-active, potentially nonneurotoxic metabolite of penclomedine by WAUD, W. R, TIWARI, A, SCHMID, S. M, SHIH, T.-W, STRONG, J. M, HARTMAN, N. R, O'REILLY, S, STRUCK, R. F

    Published in Cancer research (Chicago, Ill.) (01-03-1997)
    “…Penclomedine [3,5-dichloro-4,6-dimethoxy-2-(trichloromethyl)pyridine], an antitumor agent, is currently in Phase I clinical trials and is believed to be a…”
    Get full text
    Journal Article
  13. 13

    Pharmacokinetics of intraventricular and intravenous N,N',N″-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humans by STRONG, J. M, COLLINS, J. M, LESTER, C, POPLACK, D. G

    Published in Cancer research (Chicago, Ill.) (01-12-1986)
    “…The cerebrospinal fluid (CSF) and plasma pharmacokinetics of N,N',N"-triethylenethiophosphoramide (thiotepa), an alkylating agent used for treatment of…”
    Get full text
    Journal Article
  14. 14

    Clinical pharmacology of 5-iodo-2'-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation by Klecker, Jr, R W, Jenkins, J F, Kinsella, T J, Fine, R L, Strong, J M, Collins, J M

    Published in Clinical pharmacology and therapeutics (01-07-1985)
    “…We describe the clinical pharmacology and metabolism of 5-iodo-2'-deoxyuridine (IdUrd) during and after a 12-hour infusion. The kinetics of IdUrd were linear…”
    Get more information
    Journal Article
  15. 15

    Glutamine and glutamate: automated quantification and isotopic enrichments by gas chromatography/mass spectrometry by Anderson, L W, Zaharevitz, D W, Strong, J M

    Published in Analytical biochemistry (01-06-1987)
    “…A method is described for simultaneous quantification of glutamine and glutamate plasma levels and isotopic enrichments in these compounds. Glutamine and…”
    Get more information
    Journal Article
  16. 16

    The involvement of cytochrome P450 3A4 in the N-demethylation of L-α-acetylmethadol (LAAM), norLAAM, and methadone by MOODY, D. E, ALBURGES, M. E, PARKER, R. J, COLLINS, J. M, STRONG, J. M

    Published in Drug metabolism and disposition (01-12-1997)
    “…The N-demethylation of LAAM, norLAAM, and methadone has been investigated in human liver microsomes and microsomes containing cDNA-expressed human P450s. Gas…”
    Get full text
    Journal Article
  17. 17

    Absolute bioavailability in man of N-acetylprocainamide determined by a novel stable isotope method by Strong, J M, Dutcher, J S, Lee, W K, Atkinson, Jr, A J

    Published in Clinical pharmacology and therapeutics (01-11-1975)
    “…Absorption of a single oral dose of N-acetylprocainamide (NAPA) was studied in 3 normal subjects. Approximately 85% of the oral dose was absorbed and peak…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20

    Analysis of the active lactone form of 9-aminocamptothecin in plasma using solid-phase extraction and high-performance liquid chromatography by Takimoto, C H, Klecker, R W, Dahut, W L, Yee, L K, Strong, J M, Allegra, C J, Grem, J L

    “…We have developed a sensitive HPLC assay to quantitate the active lactone form of 9-aminocamptothecin (9AC) in human plasma over the concentration range…”
    Get more information
    Journal Article